DIANE GARRIDO-TANCREDI: Open Payments
NPI 1528424868 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,703 in 118 payments from 20 companies in 2025. Trend: 2023 $1,840 · 2024 $1,813 · 2025 $2,703
Food & beverage: $2,703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $387 |
| Ardelyx, Inc. | 17 | $281 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $240 |
| Intercept Pharmaceuticals, Inc. | 8 | $219 |
| Ipsen Biopharmaceuticals, Inc | 4 | $211 |
| PFIZER INC. | 5 | $189 |
| Madrigal Pharmaceuticals | 4 | $187 |
| EVOKE PHARMA, INC. | 7 | $181 |
| Lilly USA, LLC | 7 | $151 |
| Janssen Biotech, Inc. | 8 | $146 |
Products named: IBSRELA, XIFAXAN, OCALIVA, IQIRVO, LINZESS, VELSIPITY, REZDIFFRA, GIMOTI.
Industry payments across FL — which companies pay providers there.
